Log in

NASDAQ:SYNH - Syneos Health Stock Price, Forecast & News

$36.18
-3.24 (-8.22 %)
(As of 04/2/2020 05:02 AM ET)
Today's Range
$35.60
Now: $36.18
$37.99
50-Day Range
$32.64
MA: $56.48
$73.63
52-Week Range
$30.02
Now: $36.18
$74.25
Volume767,900 shs
Average Volume733,465 shs
Market Capitalization$3.77 billion
P/E Ratio29.18
Dividend YieldN/A
Beta1.18
Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including medication adherence, communications, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More
Syneos Health logo

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SYNH
CUSIPN/A
Phone919-876-9300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.68 billion
Cash Flow$4.64 per share
Book Value$29.19 per share

Profitability

Net Income$131.26 million

Miscellaneous

Employees24,000
Market Cap$3.77 billion
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive SYNH News and Ratings via Email

Sign-up to receive the latest news and ratings for SYNH and its competitors with MarketBeat's FREE daily newsletter.


Syneos Health (NASDAQ:SYNH) Frequently Asked Questions

How has Syneos Health's stock been impacted by COVID-19 (Coronavirus)?

Syneos Health's stock was trading at $57.30 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SYNH stock has decreased by 36.9% and is now trading at $36.18. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Syneos Health?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Syneos Health.

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Syneos Health.

How were Syneos Health's earnings last quarter?

Syneos Health Inc (NASDAQ:SYNH) posted its quarterly earnings results on Thursday, February, 20th. The company reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $0.02. The company had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.19 billion. Syneos Health had a return on equity of 10.12% and a net margin of 2.81%. The firm's revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.95 EPS. View Syneos Health's earnings history.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health updated its FY20 earnings guidance on Thursday, February, 20th. The company provided earnings per share guidance of $3.58-3.78 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.65. The company issued revenue guidance of $4.88-5.00 billion, compared to the consensus revenue estimate of $4.94 billion.

What price target have analysts set for SYNH?

11 brokers have issued twelve-month target prices for Syneos Health's stock. Their forecasts range from $45.00 to $82.00. On average, they anticipate Syneos Health's share price to reach $65.70 in the next year. This suggests a possible upside of 81.6% from the stock's current price. View analysts' price targets for Syneos Health.

Has Syneos Health been receiving favorable news coverage?

News stories about SYNH stock have trended very negative recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Syneos Health earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutSyneos Health.

Are investors shorting Syneos Health?

Syneos Health saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 6,199,900 shares, a drop of 6.3% from the February 27th total of 6,620,000 shares. Based on an average daily volume of 1,569,000 shares, the short-interest ratio is currently 4.0 days. Approximately 10.0% of the shares of the stock are sold short. View Syneos Health's Current Options Chain.

Who are some of Syneos Health's key competitors?

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Square (SQ), Netflix (NFLX), Constellation Brands (STZ), UnitedHealth Group (UNH), Verizon Communications (VZ), JD.Com (JD) and Micron Technology (MU).

Who are Syneos Health's key executives?

Syneos Health's management team includes the following people:
  • Mr. Alistair Macdonald, CEO & Director (Age 49)
  • Mr. Jason M. Meggs, Chief Financial Officer (Age 43)
  • Mr. Jonathan Olefson, Gen. Counsel & Corp. Sec. (Age 43)
  • Mr. Michael Adam Bell, Consultant (Age 63)
  • Mr. Robert Parks, Exec. VP & Chief Accounting Officer

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $36.18.

How big of a company is Syneos Health?

Syneos Health has a market capitalization of $3.77 billion and generates $4.68 billion in revenue each year. The company earns $131.26 million in net income (profit) each year or $2.83 on an earnings per share basis. Syneos Health employs 24,000 workers across the globe. View additional information about Syneos Health.

What is Syneos Health's official website?

The official website for Syneos Health is http://www.syneoshealth.com/.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at 919-876-9300 or via email at [email protected]


MarketBeat Community Rating for Syneos Health (NASDAQ SYNH)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  510 (Vote Outperform)
Underperform Votes:  411 (Vote Underperform)
Total Votes:  921
MarketBeat's community ratings are surveys of what our community members think about Syneos Health and other stocks. Vote "Outperform" if you believe SYNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SYNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel